SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing heightened volatility due to recent downgrades from Bank of America and Goldman Sachs, which many in the community are interpreting as manipulative tactics by competing institutions. Despite the short-term price pressure, a significant portion of investors remain highly bullish, viewing the dip as a prime buying opportunity ahead of upcoming earnings and potential S&P inclusion, confident in the company's long-term growth trajectory.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending amidst its CES 2026 presence, where CEO Lisa Su unveiled new AI processors and a robust product roadmap, including the MI500 series aimed at significant AI performance gains. Despite an initial sell-off and community chatter about market manipulation, many are actively 'buying the dip,' bullish on AMD's aggressive product roadmap and long-term potential in the burgeoning AI and data center markets, challenging rivals like Nvidia.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant market momentum, primarily fueled by reports of persistent memory shortages and increasing demand for its storage solutions within the rapidly expanding AI infrastructure. This has created a highly polarized community discussion, with some investors celebrating its 'unstoppable' rise as a 'generational shift,' while others caution about an overextended 'bubble' and potential for sharp pullbacks.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following its CES announcements, showcasing the Vera Rubin AI supercomputer and Alpamayo platform for autonomous vehicles. While enthusiasts celebrate these innovations as transformative for AI and robotics, many traders express frustration over the stock's struggle to sustain gains amid perceived market manipulation. The broader context reinforces NVIDIA's expanding role as a foundational technology provider in the evolving AI economy.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending after multiple analyst upgrades, with several firms designating it a "top pick" for 2026 and initiating or raising outlooks for a multi-year recovery. The community is actively discussing the stock's potential as a defensive play and a "safe haven" for capital, anticipating upward movement driven by strong fundamentals and upcoming financial reports.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis is surging after announcing positive Phase 3 results for its oral TYK2 inhibitor, envudeucitinib, in moderate-to-severe plaque psoriasis, showcasing strong skin clearance and a favorable safety profile that outperformed existing treatments. The community is buzzing with optimism about the drug's "best-in-class" potential and significant market opportunity, while others remain cautious, anticipating a potential secondary offering following the initial spike.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY Coin is currently trending with heightened trading volume, fueled by strong community anticipation for significant 2026 developments across decentralized AI, DePIN, and secure data monetization via its Layer-2 network. Supporters emphasize its foundational utility, regulatory compliance in Japan, and ex-Sony leadership as key strengths, though some investors remain cautious due to historical price volatility.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending following an agreement for Project TETRA, a DOE initiative to construct and operate a pilot reactor, which the community sees as a significant federal fast-track contract. Investors are actively comparing it to OKLO, highlighting its molten salt reactor technology and government backing as key differentiators for powering the growing demands of the AI revolution and industrial heat. Many view current levels as a long-term accumulation opportunity within the advanced nuclear sector.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

PMGC Holdings Inc.

PMGC Holdings Inc. (ELAB) is experiencing extreme volatility following a recent reverse stock split that created an exceptionally low float, driving community speculation about a potential short squeeze due to high cost-to-borrow. This comes alongside news of a strategic acquisition in the micro modular reactor sector and advancements in an AI-driven drug discovery program, though many investors express strong skepticism, citing the company's history of dilution and repeated reverse splits.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is generating significant buzz following its recent substantial debt reduction and the strategic acquisition of Ask Sage, firmly positioning the company in secure generative AI for defense and government sectors. The community is actively discussing the imminent potential for major government contract wins, often drawing comparisons to early Palantir, despite some persistent chatter about potential share dilution. Many investors foresee a breakout into double-digit prices, driven by its strengthened financial position and perceived critical role in national security applications.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

<ul class="summary-bullets"><li>Shareholders approved a reverse stock split range of 1-for-2 to 1-for-30 at a special meeting on December 5.</li><li>Split-adjusted trading will begin on the Nasdaq at market open on January 2.</li><li>The company’s quarterly sales have fallen short of Wall Street estimates in the past four quarters, according to Koyfin data.</li></ul>Shares of Co-Diagnostics Inc. (CODX) slumped 20% to an all-time low after the company announced a 1-for-30 reverse stock split, in an attempt to regain compliance with Nasdaq’s $1.00 minimum bid price rule.The reverse split will consolidate 30 outstanding shares into one, with adjustments made to stock options and warrants. Split-adjusted trading will begin on the Nasdaq at market open on January 2. The company noted that fractional shares will not be issued.Earlier, shareholders approved a reverse stock split range of 1-for-2 to 1-for-30 at a special meeting on December 5, with the board ultimately choosing the 1-for-30 option. After the reverse split becomes effective, Co-Diagnostics will have around 2.1 million outstanding shares.<h2 class="st-heading-2">2025 Highlights</h2>The company posted a weak third-quarter (Q3) print last month, with revenue falling 83% even as net loss narrowed to $5.9 million. Its quarterly sales have fallen short of Wall Street estimates in the past four quarters, according to Koyfin data.In October, Co-Diagnostics signed an agreement with Saudi Arabia–based Arabian Eagle Manufacturing to form a joint venture called CoMira Diagnostics. The JV will develop, manufacture, and commercialize Co-Dx technologies, including its polymerase chain reaction (PCR) point-of-care platform, across Saudi Arabia and 18 other countries in the Middle East and North Africa.On Monday, Co-Diagnostics said it had been granted a patent in Australia covering its new Co-Dx PCR platform, strengthening the company’s intellectual property portfolio. The patent provides broad protection in Australia for the design and operation of the Co-Dx PCR Pro instrument and test system.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits has remained in the ‘bearish’ territory over the past 24 hours.<img src="https://news.stocktwits-cdn.com/CODX_png_e909f8289e.webp" alt="CODX.png">A Stocktwits user saw a "silver lining’ in the potential low float.<stembedurl>https://stocktwits.com/Allyofall2/message/640399865</stembedurl><a href="https://stocktwits.com/symbol/CODX">CODX stock</a> has been under heavy selling pressure this year, declining more than 75%.Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/vvpr-stock-gains-on-datacenter-deal/cL7I25uREyG">VivoPower Just Announced A Deal That Could Return It To Group-Level Profitability</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ZoomInfo said net revenue retention was stable for the third consecutive quarter. 

CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval

After the reverse split becomes effective, Co-Diagnostics will have around 2.1 million outstanding shares.

Equity

Co-Diagnostics Announces Reverse Stock Split

Co-Diagnostics Announces Reverse Stock Split Co-Diagnostics Announces Reverse Stock Split PR Newswire SALT LAKE CITY, Dec. 30, 2025 SALT LAKE CITY, Dec. 30, 2025 /PRNewswire/ --Co-Diagnostics, Inc...

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies PR Newswire...

Co-Diagnostics Performs Analysis of Influenza Co-Primers to Confirm Reactivity Against Flu A H3N2 Mutation

Co-Diagnostics Performs Analysis of Influenza Co-Primers to Confirm Reactivity Against Flu A H3N2 Mutation Co-Diagnostics Performs Analysis of Influenza Co-Primers to Confirm Reactivity Against Flu A...

Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025

Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025 Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025 PR...

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India PR Newswire SALT LAKE CITY, Dec. 9, 2025 Ongoing...

CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know

CoDiagnostics (CODX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and...

Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates

CoDiagnostics (CODX) delivered earnings and revenue surprises of +15.79% and -51.67%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Co-Diagnostics Inc

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

CODX
Co-Diagnostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CODX News

CODXCo-Diagnostics Inc